ClinicalTrials.gg

Drug

Terazosin clinical trials

Also written Hytrin.

studies test it
19
open now
6
in phase 3
3
first study started
2005

Keep track of what changes. Save the Terazosin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

16 studies that test it; most in 2005 (2); 3 more planned to start later

Studies that test Terazosin, by start year
YearStudies
20052
20061
20071
20122
20181
20192
20201
20211
20231
20252
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
1
Phase 1
5
Phase 2
8
Phase 3
3
Phase 4
2
No phase
4

What it is tested for

Each study’s main condition, where its own words name it.

Who runs them

Industry 1 · Other 18

University of Iowa (2) · Thomas Jefferson University (2) · Qiang Zhang (2) · Cedars-Sinai Medical Center (1) · Jordan Schultz (1) · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany (1) · Urmia University of Medical Sciences (1) · Anhui Medical University (1)

Often tested with

Tested in the same studies.

Tolterodine (1) · Amlodipine (1) · Tamsulosin (1) · Telmisartan (1) · Doxazosin (1)

Studies

Open first, then newest update. How each study uses Terazosin is read from its arms, and is right about nine times in ten.

Testing it · 19

Codes

What other systems call Terazosin · ClinicalTrials.gg INT003143

  • MeSH (NLM) C041226TerazosinConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 8L5014XET7TERAZOSINConfirmed FDA, NLM, Wikidata
  • RxNorm 37798Confirmed FDA, Wikidata
  • Wikidata Q280786terazosinConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C61964TerazosinOne source FDA
  • DrugBank DB01162One source Wikidata

Also registered as terazosin hydrochloride (UNII D32S14F082 · RxNorm 235224) and terazosin hydrochloride anhydrous (UNII 8QOP8Z9955 · RxNorm 1299927).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.